Antheia, Inc.
The advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation
Menlo Park, United States
66 employees
Series C
Total: $238.33M
Biotechnology, Health Care +2
General Information
Menlo Park, United States
BounceWatch is an independent company data service, not affiliated with Antheia, Inc.. To contact Antheia, Inc., visit antheia.bio.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Antheia, Inc. compare?
A PDF of Antheia, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Antheia, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Antheia, Inc. on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Antheia, Inc.
Business keywords: synthetic biology, drug discovery, metabolic engineering, fermentation, advanced manufacturing, medicinal power, biomanufacturing, pharmaceutical supply chain, API production, yeast engineering, essential medicines, rapid response, whole cell engineering, plant inspired medicines
Funding Rounds & Investors (12)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | $24.00M | 4 |
|
01 Jan 2026 |
| Series C | $56.00M | 7 |
|
01 Jun 2025 |
| Grant | $17.00M | 4 |
|
01 Jul 2024 |
| Debt Financing | $40.00M | 1 |
|
01 Jun 2022 |
| Series B | $73.00M | 3 |
|
01 Jun 2021 |
| Early VC | $9.20M | - |
|
01 Sep 2018 |
| Grant | $1.20M | 1 |
|
01 Mar 2018 |
| Series A | $9.50M | - |
|
01 Oct 2017 |
| Early VC | $6.20M | - |
|
01 May 2017 |
| Grant | $230.00K | 1 |
|
01 Jun 2016 |
Antheia, Inc. Alternatives & Competitors
View All Alternatives
UK-based pharmaceutical company focused on R&D, cultivation, production and sale of cannabis-based m...
Previously impossible enzymes for your visionary products
Enabling next generation medicines.
FAQ About Antheia, Inc.
Source: BounceWatch company record for Antheia, Inc., https://bouncewatch.com/company/antheia-inc, updated 25 June 2026. When citing, please name BounceWatch and link this page.
